盐酸纳美芬，CAS 登记号 58895-64-0，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 盐酸纳美芬 的 CAS 号：58895-64-0，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Nalmefene hydrochloride · CAS 58895-64-0 · C21H26ClNO3. UNII K7K69QC05X.
| CAS Registry Number | 58895-64-0 |
|---|---|
| PubChem CID | 5388881 |
| Molecular formula | C21H26ClNO3 |
| IUPAC name | (4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride |
| UNII (FDA) | K7K69QC05X |
| Molecular Weight | 375.9 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 375.1601214 |
| Monoisotopic Mass | 375.1601214 |
| Topological Polar Surface Area | 52.9 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 618 |
| Reported hazard statements | H302 (95.2%), H312 (85.7%), H317 (85.7%), H332 (90.5%), H334 (81%) |
|---|
H302 (95.2%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (85.7%): Harmful in contact with skin [Warning Acute toxicity, dermal]
Nalmefene hydrochloride; 58895-64-0; Nalmefene HCl; Revex; opvee; ZURNAI; JF-1 HYDROCHLORIDE; K7K69QC05X; DTXSID70891705; RefChem:57226; nalmefene hydrochloride injection; DTXCID901030833; Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, Hydrochloride,(5alpha)-; Nalmefenehydrochloride; UNII-K7K69QC05X; Revex (TN)
CAS 58895-64-0; molecular formula C21H26ClNO3; molecular weight — g/mol.
Nalmefene hydrochloride, 58895-64-0, Nalmefene HCl, Revex, opvee, ZURNAI.
Hazard statements reported: H302, H312, H317, H332, H334.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.